← American Pharmacists Association (APhA)
FDANonrulemakingFDA-2025-N-6743

Food and Drug Administration Expert Panel on Testosterone Replacement Therapy for Men; Request for Information

RIN
—
Last modified
Jan 14, 2026
Comment window
closed 169d ago
American Pharmacists Association (APhA) filings
1

Activity

American Pharmacists Association (APhA) filed 1 comment on this docket between Feb 20, 2026 and Feb 20, 2026. 11 other organizations filed here. The comment window closed 169d ago.

What American Pharmacists Association (APhA) filed (1)

Feb 20, 2026· Comment from American Pharmacists Association (APhA)· FDA-2025-N-6743-1911

Dear Acting Deputy Commissioner Zeta, The American Pharmacists Association (APhA) appreciates the opportunity to provide comments on the "Food and Drug Administration Expert Panel on Testosterone Replacement Therapy for Men; Request for Information." APhA writes to highlight pharmacists' integral role in patient access, education, compounding, and administration of testosterone replacement therapy. APhA represents pharmacists, student pharmacists, and pharmacy technicians in all practice settings, including but not limited to community pharmacies, hospitals, long-term care facilities, specialty pharmacies, community health centers, physician offices, ambulatory clinics, managed care organizations, hospice settings, and government facilities. Our members strive to improve medication use, advance patient care, and enhance public health. Full comments are attached.

View on regulations.gov →

Abstract

OPEN

View on regulations.gov →

Co-filers (11)

See everyone who commented →